The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New insights into the pharmacodynamic and pharmacokinetic properties of statins
Corsini, A., Bellosta, S., Baetta, R., Fumagalli, R., Paoletti, R., & Bernini, F. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00045-5 · Cited by 796
Clinical Pharmacokinetics of Atorvastatin
Lennern??s, H. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342130-00005 · Cited by 623
Supercritical antisolvent precipitation of micro- and nano-particles
Reverchon, E. (1999) · The Journal of Supercritical Fluids · doi:10.1016/s0896-8446(98)00129-6 · Cited by 617
Physical pharmacy. Physical chemical principles in the pharmaceutical sciences
(1984) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(84)90019-3 · Cited by 613
Khankari, R. K., & Grant, D. J. W. (1995) · Thermochimica Acta · doi:10.1016/0040-6031(94)01952-d · Cited by 485
Pharmaceutical Processing with Supercritical Carbon Dioxide
Subramaniam, B., Rajewski, R. A., & Snavely, K. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js9700661 · Cited by 444
Particle engineering techniques for inhaled biopharmaceuticals
Shoyele, S. A., & Cawthorne, S. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.010 · Cited by 301
Joung, S. N., Yoo, C. W., Shin, H. Y., Kim, S. Y., Yoo, K., Lee, C. S., & Huh, W. S. (2001) · Fluid Phase Equilibria · doi:10.1016/s0378-3812(01)00472-1 · Cited by 242
Won, D.-H., Kim, M.-S., Lee, S., Park, J.-S., & Hwang, S.-J. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.05.017 · Cited by 216
Self-citationCilla, D. D., Whitfield, L. R., Gibson, D. M., Sedman, A. J., & Posvar, E. L. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90218-0 · Cited by 204
Shen, H., & Zhong, M. (2006) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.9.0004 · Cited by 199
Theoretical and Experimental Studies of Transport of Micelle-Solubilized Solutes
Amidon, G. E., Higuchi, W. I., & Ho, N. F. H. (1982) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600710120 · Cited by 192
Rantakylä, M., Jäntti, M., Aaltonen, O., & Hurme, M. (2002) · The Journal of Supercritical Fluids · doi:10.1016/s0896-8446(02)00034-7 · Cited by 120
Vaughn, J. M., McConville, J. T., Crisp, M. T., et al. (2006) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040500529176 · Cited by 53
Cited by
Sapsford, K. E., Algar, W. R., Berti, L., Gemmill, K. B., Casey, B. J., Oh, E., Stewart, M. H., & Medintz, I. L. (2013) · Chemical Reviews · doi:10.1021/cr300143v · Cited by 1,423
Baghel, S., Cathcart, H., & O'Reilly, N. J. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2015.10.008 · Cited by 970
Pharmaceutical amorphous solid dispersion: A review of manufacturing strategies
Bhujbal, S. V., Mitra, B., Jain, U., Gong, Y., Agrawal, A., Karki, S., Taylor, L. S., Kumar, S., & (Tony) Zhou, Q. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.05.014 · Cited by 556
Sinha, B., Müller, R. H., & Möschwitzer, J. P. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.01.019 · Cited by 523
Understanding the Behavior of Amorphous Pharmaceutical Systems during Dissolution
Alonzo, D. E., Zhang, G. G. Z., Zhou, D., Gao, Y., & Taylor, L. S. (2010) · Pharmaceutical Research · doi:10.1007/s11095-009-0021-1 · Cited by 473
Metadata
- Authors
- Kim, M.-S., Jin, S.-J., Kim, J.-S., Park, H. J., Song, H.-S., Neubert, R. H. H., & Hwang, S.-J.
- Venue
- European Journal of Pharmaceutics and Biopharmaceutics
- Publisher
- Elsevier BV
- Published
- 2008-06
- Volume
- 69
- Issue
- 2
- Pages
- 454-465
- ISSN
- 0939-6411 (ISSN-L)
- OpenAlex
- W1970005269
- Cited by
- 265
- References
- 14
- FWCI
- 11.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.